April's Insider Flow简体 · 繁體
醫療保健 · Healthcare

ROIV · Roivant Sciences Ltd.

內部人交易(Form 4)· Insider trading · 2026-07-01 – 2026-10-22

Roivant Sciences Ltd.(ROIV)內部人交易:2026-07-01 至 2026-10-22,內部人公開市場買入 —、賣出 $67.8M;高管董事有效買入 —、有效賣出 —。最近申報 2026-10-22。

買入 Bought—
賣出 Sold$67.8M
有效買入 Effective bought—
有效賣出 Effective sold—
開啟互動頁面(K 線、成交價圖)Open interactive page →

最近申報 Recent filings

交易日內部人類型股數價格金額
2026-10-20Venker Eric
President & Immunovant CEO
賣出 Sell200,000$35.11$7.0MSEC
2026-10-01Epperly Melissa B,
Director
賣出 Sell17,750$36.10$641KSEC
2026-09-30Venker Eric
President & Immunovant CEO
賣出 Sell200,000$36.62$7.3MSEC
2026-09-15Epperly Melissa B,
Director
賣出 Sell4,938$39.74$196KSEC
2026-09-15Fitzgerald Meghan
Director
賣出 Sell5,112$39.74$203KSEC
2026-09-08Fitzgerald Meghan
Director
賣出 Sell20,000$39.90$798KSEC
2026-08-28Venker Eric
President & Immunovant CEO
賣出 Sell200,000$35.77$7.2MSEC
2026-08-19Sukhatme Mayukh
Director, President & CIO
賣出 Sell335,174$36.88$12.4MSEC
2026-08-14Sukhatme Mayukh
Director, President & CIO
賣出 Sell664,826$36.34$24.2MSEC
2026-07-27Venker Eric
President & Immunovant CEO
賣出 Sell200,000$34.95$7.0MSEC
2026-06-30Fitzgerald Meghan
Director
賣出 Sell10,000$34.90$349KSEC
2026-06-29Epperly Melissa B,
Director
賣出 Sell17,750$34.38$610KSEC
「有效」= 高管或董事的公開市場主動買賣,排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。

擬出售 Form 144

預計出售日申報人股數約金額
2026-10-20Venker Eric
Officer
200,000$7.0M10b5-1
2026-09-30Venker Eric
Officer
200,000$7.3M10b5-1
2026-09-15Epperly Melissa B,
Director
22,688$931K10b5-1
2026-09-15Fitzgerald Meghan
Officer
5,112$210K10b5-1
2026-09-08Fitzgerald Meghan
Director
20,000$699K10b5-1
2026-08-28Venker Eric
Officer
200,000$7.1M10b5-1
2026-08-21Sukhatme Mayukh
Officer, Director
144,756$5.3M
2026-08-20Sukhatme Mayukh
Officer, Director
17,519$653K
2026-08-19Sukhatme Mayukh
Officer, Director
172,899$6.4M
2026-08-18Sukhatme Mayukh
Officer, Director
136,942$5.0M

內部人 Insiders

Venker Eric、Epperly Melissa B,、Fitzgerald Meghan、Sukhatme Mayukh